AB130. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway - He, Dalin; Li, Lei; Zhu, Gguodong; Liang, Liang; Guan, Zhenfeng; Chang, Luke; Chen, Yuan; Yeh, Shuyuan; Chang, Chawnshang (Translational Andrology and Urology; Vol 3, Supplement 1 (September 12, 2014): Translational Andrology and Urology, 2014)